What Brand Owners Get Wrong About Herbal Manufacturing
The expensive mistakes in this industry are not dramatic. They are a handful of reasonable-sounding assumptions. Each of these costs brand owners real money every year, and each is avoidable with a question asked at the right time.
Nine Assumptions Worth Examining
This guide is for brand owners manufacturing herbal, Ayurvedic and supplement products in India, drawn from what recurs across launches.
None of the following is a foolish mistake. Each is a reasonable assumption that happens to be wrong, which is why they recur across otherwise capable businesses.
The Assumptions
In rough order of expense.
- That a manufacturer having a licence means the licence covers your product. Scope matters, not existence, and a licence not covering your dosage form or category does not make your product lawful.
- That the cheapest quotation is the best value. A materially lower price usually reflects a different specification rather than greater efficiency: a different plant part, no marker standardisation, a narrower testing panel or lighter documentation.
- That naming an ingredient specifies it. An extract without a plant part, marker and percentage is undefined, and two suppliers quoting the same ingredient can supply materially different material.
- That the production minimum is the minimum. Packaging minimums are usually higher and printed components cannot be reused, so packaging sets the real commitment.
- That traditional use permits a claim. It does not, and nor does published research, nor competitor practice. The permitted claim set is narrower than market practice suggests.
- That stability data provided is yours. Data for a different pack or formulation does not substantiate your shelf life, and this is accepted loosely more often than almost anything else.
- That certificates of analysis are paperwork. They are your quality control, and filing them unread provides a record that a document existed rather than any verification.
- That records can be assembled when needed. Batch traceability, artwork review records and dispatch records cannot be reconstructed during an incident or an audit.
- That a volume discount is a saving. It is, and it is also cash converted into stock with an expiry date, which is how brands with real demand run out of money.
What Each One Costs
The connection between assumption and consequence.
| Assumption | Typical Cost |
|---|---|
| Licence scope unchecked | A product that cannot be lawfully sold, discovered late |
| Cheapest quotation accepted | A different product than intended, and inconsistency |
| Ingredient not specified | Batch-to-batch variation and lost reorders |
| Packaging minimum unplanned | Cash locked in components and write-offs |
| Claims assumed available | Listing removals, regulatory queries, returns |
| Stability data accepted loosely | An unsubstantiated shelf life on every pack |
| Certificates filed unread | An out-of-specification batch shipped unnoticed |
| Records left until needed | An unanswerable question from a buyer or regulator |
| Volume discount taken | Expired stock and a cash shortage |
Notice how many of these surface months after the decision. That delay is why the same assumptions recur: the cost is rarely attributed to the choice that caused it.
The Questions That Prevent Them
One question per assumption, asked at the right moment.
Before Choosing a Manufacturer
May I see the licence showing it covers this dosage form and category?
Before Accepting a Quotation
What differs in specification between this and a higher quotation?
Before Finalising a Formulation
For each extract: which plant part, which marker, at what percentage, by which method?
Before Committing to a Batch
What are the production and packaging minimums, separately?
Before Writing Any Copy
What claims are actually available for this product and category?
Before Printing a Date
Was this stability data generated on my formulation in my pack?
Each question takes a minute and prevents a cost that arrives months later. That asymmetry is the practical argument for asking them.
What Experienced Brand Owners Do Differently
Four habits that separate second products from first ones.
- They specify precisely and negotiate price afterwards, rather than the reverse.
- They build the product file during launch, while the documents are arriving anyway.
- They secure written change control, because they have experienced an unannounced change.
- They size batches against shelf life and cash rather than against unit cost.
Checklist
Work through before your next launch.
- Verify licence scope against your dosage form and category.
- Ask what differs in any unusually cheap quotation.
- Specify plant part, marker and percentage for every extract.
- Get production and packaging minimums separately.
- Establish what claims are available before writing copy.
- Confirm stability data is for your formulation and pack.
- Read every certificate of analysis against the specification.
- Build the product file as you launch, not later.
- Secure written change control.
- Size the batch against shelf life and available cash.
- Record the reasoning, so the next launch starts further along.
Want These Questions Answered Up Front?
Share your product and our team will respond with licence scope, specification detail, testing and realistic minimums.
Frequently Asked Questions
What is the single most expensive assumption?
That a manufacturer having a licence means it covers your product. Scope matters rather than existence, and discovering late that the licence does not cover your dosage form or category can mean a product that cannot lawfully be sold.
Why is the cheapest quotation usually not the best value?
Because a materially lower price generally reflects a different specification rather than greater efficiency: a different plant part, no marker standardisation, a narrower testing panel or lighter documentation. Ask what differs before concluding you found a better price.
Why do packaging minimums matter more than production minimums?
Because printed components usually carry higher minimums and cannot be reused across SKUs, which makes packaging the real floor on your commitment and the most common source of unrecoverable early losses.
Why is accepting stability data loosely a problem?
Because data generated on a different formulation or in a different pack does not substantiate your shelf life, which means the expiry date on every pack is an unsupported claim. This is accepted loosely more often than almost anything else.
What do experienced brand owners do differently?
They specify precisely and negotiate price afterwards, build the product file during launch while documents are arriving, secure written change control because they have experienced an unannounced change, and size batches against shelf life and cash rather than unit cost.